ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,027,485 | +13.5% | 613,921 | 0.0% | 6.74% | +97.9% |
| Q2 2023 | $19,412,182 | -30.7% | 613,921 | -32.5% | 3.41% | -41.2% |
| Q1 2023 | $28,024,129 | -5.5% | 909,579 | -5.0% | 5.79% | -9.3% |
| Q4 2022 | $29,661,832 | +48.5% | 957,451 | -10.0% | 6.38% | +37.1% |
| Q3 2022 | $19,968,000 | +3.8% | 1,063,835 | 0.0% | 4.66% | -9.2% |
| Q2 2022 | $19,234,000 | +37.2% | 1,063,835 | +6.4% | 5.13% | +45.3% |
| Q1 2022 | $14,016,000 | – | 999,727 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $99,440,000 | 48.67% |
| AJU IB Investment Co., Ltd. | 1,380,890 | $24,966,000 | 48.34% |
| NEA Management Company, LLC | 6,750,264 | $112,703,000 | 5.79% |
| Samsara BioCapital, LLC | 1,063,835 | $19,234,000 | 5.13% |
| Novo Holdings A/S | 4,016,878 | $72,625,000 | 3.58% |
| CLOUGH CAPITAL PARTNERS L P | 1,165,533 | $20,953,000 | 2.60% |
| Soleus Capital Management, L.P. | 909,739 | $16,448,000 | 2.57% |
| CAXTON CORP | 101,719 | $1,839,000 | 2.47% |
| Cormorant Asset Management, LP | 1,525,000 | $27,572,000 | 2.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,470,559 | $44,668,000 | 1.70% |